Guidance Lists Suspect Product Scenarios Requiring FDA Notification

The FDA finalized guidance in December on suspect products and notification, describing when to file a report, and added example scenarios of fraudulent activity that would warrant alerting the agency, trading partners and wholesale distributors.
Source: Drug GMP Report